top of page
Established mid-size biopharma company gained launch strategy and plan.
Launch Strategy & Planning
A clinical stage biopharma company gained a forecast for new chemical entity in phase 2 for the treatment of glaucoma.
Forecasts and commercial assessments
A biopharma company gained scientific platform for their innovation in phase 3.
Scientific Communication Platform Development
Emerging biopharma company gained understanding of the competitive environment of specific fusion proteins across multiple diseases areas.
Emerging biopharma company gained strategy for clinical development knowing the market size and opportunity for Parkinson’s disease.
Market Landscape Assessments
Emerging biopharma company gained target product for multiple cancer indications.
Target Product Profile
Medical device company gained patient profiles for their medical device launch.
Emerging biopharma company included outcomes endpoints in phase 3 protocol using patient journey maps.
CEO and CFO were confident that the decisions they make about their portfolios will generate lasting value.
Portfolio Analytics & Prioritization
Add paragraph text. Click “Edit Text” to customize this theme across your site. You can update and reuse text themes.
Examples of our work with clients
bottom of page